Aisling Capital Ii Lp - Net Worth and Insider Trading
Aisling Capital Ii Lp Net Worth
The estimated net worth of Aisling Capital Ii Lp is at least $78 Million dollars as of 2024-09-20. Aisling Capital Ii Lp is the 10% Owner of ADMA Biologics Inc and owns about 3,620,143 shares of ADMA Biologics Inc (ADMA) stock worth over $71 Million. Aisling Capital Ii Lp is also the 10% Owner of Esperion Therapeutics Inc and owns about 3,741,719 shares of Esperion Therapeutics Inc (ESPR) stock worth over $6 Million. Details can be seen in Aisling Capital Ii Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aisling Capital Ii Lp has not made any transactions after 2015-04-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aisling Capital Ii Lp
Aisling Capital Ii Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aisling Capital Ii Lp owns 5 companies in total, including ViewRay Inc (VRAYQ) , Esperion Therapeutics Inc (ESPR) , and Cidara Therapeutics Inc (CDTX) among others .
Click here to see the complete history of Aisling Capital Ii Lp’s form 4 insider trades.
Insider Ownership Summary of Aisling Capital Ii Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRAYQ | ViewRay Inc | 2016-03-30 | 10 percent owner |
| ESPR | Esperion Therapeutics Inc | 2015-04-24 | 10 percent owner |
| CDTX | Cidara Therapeutics Inc | 2015-04-14 | 10 percent owner |
 | | 2013-10-22 | 10 percent owner |
| | 2012-02-07 | 10 percent owner |
Aisling Capital Ii Lp Latest Holdings Summary
Aisling Capital Ii Lp currently owns a total of 2 stocks. Among these stocks, Aisling Capital Ii Lp owns 3,620,143 shares of ADMA Biologics Inc (ADMA) as of October 22, 2013, with a value of $71 Million and a weighting of 91.67%. Aisling Capital Ii Lp also owns 3,741,719 shares of Esperion Therapeutics Inc (ESPR) as of April 24, 2015, with a value of $6 Million and a weighting of 8.33%.
Latest Holdings of Aisling Capital Ii Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADMA | ADMA Biologics Inc | 2013-10-22 | 3,620,143 | 19.73 | 71,425,421 |
| ESPR | Esperion Therapeutics Inc | 2015-04-24 | 3,741,719 | 1.74 | 6,491,882 |
Holding Weightings of Aisling Capital Ii Lp
Aisling Capital Ii Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Aisling Capital Ii Lp has made a total of 0 transactions in ADMA Biologics Inc (ADMA) over the past 5 years. The most-recent trade in ADMA Biologics Inc is the acquisition of 411,765 shares on October 22, 2013, which cost Aisling Capital Ii Lp around $4 Million.
According to the SEC Form 4 filings, Aisling Capital Ii Lp has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the sale of 217,469 shares on April 24, 2015, which brought Aisling Capital Ii Lp around $24 Million.
Insider Trading History of Aisling Capital Ii Lp
- 1
Aisling Capital Ii Lp Trading Performance
GuruFocus tracks the stock performance after each of Aisling Capital Ii Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aisling Capital Ii Lp is 16.46%. GuruFocus also compares Aisling Capital Ii Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Aisling Capital Ii Lp within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Aisling Capital Ii Lp's insider trading performs compared to the benchmark.
Performance of Aisling Capital Ii Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.72 | | | | | |
| Relative Return to S&P 500(%) | 7.45 | | | | | |
Aisling Capital Ii Lp Ownership Network
Aisling Capital Ii Lp Owned Company Details
What does ViewRay Inc do?
Who are the key executives at ViewRay Inc?
Aisling Capital Ii Lp is the 10 percent owner of ViewRay Inc. Other key executives at ViewRay Inc include SVP & General Counsel Sanket Shah , 10 percent owner Farhad Fred Ebrahimi , and Chief Commercial Officer Paul Jr Ziegler .
ViewRay Inc (VRAYQ) Insider Trades Summary
Over the past 18 months, Aisling Capital Ii Lp made no insider transaction in ViewRay Inc (VRAYQ). Other recent insider transactions involving ViewRay Inc (VRAYQ) include a net sale of 110,324 shares made by B Kristine Johnson , a net sale of 8,203,610 shares made by Farhad Fred Ebrahimi , and a net sale of 2,408,747 shares made by Scott William Drake .
In summary, during the past 3 months, insiders sold 0 shares of ViewRay Inc (VRAYQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,487,227 shares of ViewRay Inc (VRAYQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 13,487,227 shares.
ViewRay Inc (VRAYQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
ViewRay Inc Insider Transactions
Aisling Capital Ii Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Aisling Capital Ii Lp. You might contact Aisling Capital Ii Lp via mailing address: 88 Seventh Ave 30th Fl, New York Ny 10106.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
